Global percutaneous nephrolithotomy Market
Healthcare Services

Comprehensive Analysis of the Percutaneous Nephrolithotomy Market 2025-2034: Growth Rates, Trends, and Future Opportunities

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the Percutaneous Nephrolithotomy Market from 2025 to 2034, and What Factors Influence It?

In recent times, the size of the percutaneous nephrolithotomy market has seen substantial growth. It is slated to escalate from a worth of $17.9 billion in 2024 on to a value of $19.54 billion in 2025, experiencing a compound annual growth rate (CAGR) of 9.1%. Several reasons have contributed to this growth in the historic period, which include a rise in the occurrence of kidney stones, an increased demand for effective and efficient kidney stone treatments, the broadening of healthcare infrastructure in developing economies, the increasing age of the population which leads to a higher recurrence of kidney stones, a spike in research and development activities, an increase in healthcare spending, and a growing focus on healthcare that prioritises the patient.

Strong growth is anticipated in the percutaneous nephrolithotomy market over the coming years, reaching an expected value of $27.36 billion in 2029. This translates into a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this projected growth include increasing integration of minimally invasive procedures, growing demand for efficient stone removal methods, and heightened awareness of the benefits of percutaneous nephrolithotomy. Additional factors include the enlarging older population susceptible to kidney stones, improved access to sophisticated stone removal technologies, a patient-oriented approach to healthcare, and an increased preference for outpatient procedures. Upcoming trends forecasted include the incorporation of miniaturized tools, evolution in imaging technologies, the introduction of robotics, utilization of disposable equipment, advancements in stone retrieval devices and anesthesia techniques, enhanced infection control measures, multimodal pain management strategies, and the establishment of training programs.

What Are the Primary Drivers Supporting the Growth of the Percutaneous Nephrolithotomy Market?

The escalating prevalence of renal diseases is anticipated to fuel the expansion of the percutaneous nephrolithotomy market. Renal diseases entail a variety of conditions which negatively affect the kidneys, inhibiting their normal function. The surge in renal disease cases can be attributed to escalating diabetes and hypertension rates, an aging population, poor lifestyle habits, genetic factors, chronic illnesses, and an improvement in awareness and diagnosis. Percutaneous nephrolithotomy provides an effective solution to manage renal diseases by offering a surgical procedure with minimal invasiveness to remove large or complex kidney stones, relieving pain, warding off urinary tract infections, and enhancing kidney function. As an example, ZS Associates, a UK-based Kidney Research Commission, reported in June 2023 that the prevalence of kidney disease in the UK had impacted 7.19 million individuals in 2023, a number expected to escalate to 7.61 million by 2033. Therefore, the escalating prevalence of renal diseases is stimulating the growth of the percutaneous nephrolithotomy market. The percutaneous nephrolithotomy market growth is also expected to be fueled by the growing demand for minimally invasive surgeries. These surgeries are medical procedures that involve incisions to enter the body to diagnose or treat conditions. The rising trend of minimally invasive surgeries (MIS) is influenced by its valuable benefits including shorter recovery periods and hospital stays, reduced risk of complications, minor pain and scarring, and enhanced accuracy due to advanced technology. These types of surgeries are particularly beneficial to the percutaneous nephrolithotomy (PCNL) by offering a less invasive manner to treat kidney stones. January 2023 reports from Intuitive Surgical Inc., a US-based manufacturer of robotic products, indicate that approximately 1,875,000 surgeries were carried out using Vinci Surgical Systems in 2022, an 18% rise from the 1,594,000 surgeries performed with Vinci Surgical Systems in 2021. Therefore, the growth in the adoption of minimally invasive surgeries is driving the expansion of the percutaneous nephrolithotomy market.

Request Your Free Percutaneous Nephrolithotomy Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16506&type=smp

Who Are the Leading Players Fueling Growth in the Percutaneous Nephrolithotomy Market?

Major companies operating in the percutaneous nephrolithotomy market are:

• Boston Scientific Corporation_x000D_

• Zimmer Biomet Holdings Inc._x000D_

• Olympus Corporation_x000D_

• Terumo Corporation_x000D_

• Coloplast Corporation_x000D_

What Are the Emerging Trends Shaping the Future of the Percutaneous Nephrolithotomy Market?

Leading businesses in the percutaneous nephrolithotomy market are turning to innovative solutions like robot-assisted surgical platforms to elevate surgical accuracy and patient results. This sophisticated medical system utilizes robotic technology to aid surgeons in carrying out intricate procedures with increased precision, management, and versatility. For example, in February 2023, Ethicon Inc., an American Johnson & Johnson MedTech firm, announced the successful use of the MONARCH Platform for the robotic-assisted eradication of kidney stones from the first patient. This platform enables urologists to traverse the kidney with robotic assistance crafted for access, clearance, and control, operated via a handheld controller. The MONARCH platform affords a singular platform that encompasses ureteroscopic and percutaneous nephrolithotomy (PCNL) procedures, providing superior navigation, access, clearance, and control over conventional methods.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/percutaneous-nephrolithotomy-global-market-report

How Are the Key Segments of the Percutaneous Nephrolithotomy Market Driving Opportunities and Innovations?

The percutaneous nephrolithotomy market covered in this report is segmented –

1) By Type: Magnesium Ammonium Phosphate Stone Type, Calcareous Type, Uric Acid Calculi Type

2) By Component: Accessories, Devices, Services

3) By End-User: Ambulatory Surgical Centers, Clinics, Hospitals

Subsegments:

1) By Magnesium Ammonium Phosphate Stone Type: Struvite Stones, Triple Phosphate Stones

2) By Calcareous Type: Calcium Oxalate Stones, Calcium Phosphate Stones

3) By Uric Acid Calculi Type: Primary Uric Acid Stones, Secondary Uric Acid Stones

Which Regions Are Driving Growth in the Percutaneous Nephrolithotomy Market?

North America was the largest region in the percutaneous nephrolithotomy market in 2024. The regions covered in the percutaneous nephrolithotomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the Percutaneous Nephrolithotomy Market?

Percutaneous nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove kidney stones (renal calculi) from the urinary tract. This procedure involves making a small incision in the skin and creating a direct channel to the kidney through which instruments are inserted to break up and extract the stones. PCNL is employed when other less invasive methods, such as shock wave lithotripsy or ureteroscopy, are ineffective or unsuitable.

Browse Through More Similar Reports By The Business Research Company:

Injection Molded Plastics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/injection-molded-plastics-global-market-report

Nephrologists Global Market Opportunities And Strategies To 2031

https://www.thebusinessresearchcompany.com/report/nephrologists-market

Nephrology Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nephrology-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *